39247
NOBEL ILAC SANAYII VE TICARET A.S.
Mar 21, 2017
Turkiye
Central Asia and Turkiye
Apr 23, 2017
B - Limited
Active
Nov 2, 2017
Regional Industry - MAS ECA
Health, Education and Life Sciences
Approved : Jul 27, 2017
Signed : Jul 31, 2017
Invested : Oct 31, 2017
Pharmaceuticals and Medicine
Nobel Ilac ("Nobel") is a Turkish generic pharmaceuticals company that produces, markets, distributes and sells products domestically and exports across Europe and Central Asia. Its product portfolio is spread across chronic, acute and consumer health therapeutic areas. Nobel’s investment plan of US$44.5 million encompasses its expansion into two new subsectors: (i) Biotechnology R&D and production, and (ii) the production of injectable form drugs, in addition to developing a high bay warehouse to optimize supply chain and inventory management.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation